The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...

The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management. The medication is now cleared by the FDA for clinical use in perioperative settings, ...

San Francisco police arrested a man accused of selling ecstasy, ketamine and LSD on Friday at Outside Lands. Officers ...

Manuscript accepted for publication in Frontiers in Pharmacology, “Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism ...

A woman charged with selling Matthew Perry the dose of ketamine that killed him is headed for a September trial.

Nearly two years after “Friends” star Matthew Perry's passing, his co-star and friend Jennifer Aniston has reflected on his ...

"Third time lucky as PharmaTher gets FDA approval for ketamine" was originally created and published by Pharmaceutical ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, ...

In England, the number of under-18s entering drug treatment for ketamine problems rose from 335 to 917 between 2020 and 2023, according to the National Drug Treatment Monitoring System.